Jim Simons’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-393,000
| Closed | -$578K | – | 4588 |
|
|
2022
Q2 | $578K | Sell |
393,000
-278,788
| -41% | -$205K | ﹤0.01% | 3073 |
|
|
2022
Q1 | $773K | Buy |
671,788
+162,600
| +32% | +$265K | ﹤0.01% | 2894 |
|
|
2021
Q4 | $1.27M | Buy |
+509,188
| New | +$2M | ﹤0.01% | 2471 |
|
|
2021
Q3 | – | Sell |
-58,011
| Closed | -$482K | – | 3992 |
|
|
2021
Q2 | $482K | Buy |
+58,011
| New | +$489K | ﹤0.01% | 2980 |
|
|
2019
Q4 | – | Sell |
-260,088
| Closed | -$2.68M | – | 3822 |
|
|
2019
Q3 | $2.68M | Sell |
260,088
-171,700
| -40% | -$2.17M | ﹤0.01% | 2120 |
|
|
2019
Q2 | $5.42M | Buy |
+431,788
| New | +$5.56M | ﹤0.01% | 1770 |
|
|
2019
Q1 | – | Sell |
-170,388
| Closed | -$1.05M | – | 3779 |
|
|
2018
Q4 | $1.05M | Buy |
+170,388
| New | +$1.3M | ﹤0.01% | 2549 |
|
|
2018
Q1 | – | Sell |
-155,276
| Closed | -$1.95M | – | 3652 |
|
|
2017
Q4 | $1.95M | Sell |
155,276
-75,112
| -33% | -$1.09M | ﹤0.01% | 2362 |
|
|
2017
Q3 | $4.39M | Buy |
230,388
+29,600
| +15% | +$452K | 0.01% | 1851 |
|
|
2017
Q2 | $3.03M | Buy |
200,788
+85,600
| +74% | +$1.29M | ﹤0.01% | 2017 |
|
|
2017
Q1 | $1.98M | Buy |
+115,188
| New | +$1.53M | ﹤0.01% | 2245 |
|
|
2016
Q4 | – | Sell |
-180,288
| Closed | -$1.77M | – | 3544 |
|
|
2016
Q3 | $1.77M | Buy |
180,288
+165,200
| +1,095% | +$1.51M | ﹤0.01% | 2261 |
|
|
2016
Q2 | $155K | Sell |
15,088
-14,300
| -49% | -$159K | ﹤0.01% | 3097 |
|
|
2016
Q1 | $356K | Buy |
+29,388
| New | +$297K | ﹤0.01% | 2944 |
|
Other funds holding EPZM
Jim Simons's EPZM Position: Q3 2022 in Review
Jim Simons sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 393,000 shares — an estimated $578K sold.
Jim Simons first reported a position in EPZM in Q1 2016 and held it in 14 quarters. The position peaked at $5.42M in Q2 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Jim Simons reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Jim Simons sold 393,000 Epizyme, Inc shares in Q3 2022, an estimated $578K.
- Jim Simons first reported a position in Epizyme, Inc in Q1 2016 and held it in 14 quarters.
- Jim Simons's Epizyme, Inc position peaked at $5.42M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.